Publications by authors named "Luke Zheng"

Claim this Profile
R
Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry.
Amarnath R Annapureddy, Karthik Murugiah, Luke Zheng, Karl E Minges, Gowtham R Grandhi

Am Heart J· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients.
Natasha J Burke, Lisa M Mendelson, Tracy Joshi, Caryn Libbey, Eric J Burks, Luke Zheng

Amyloid· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: Rationale and design.
Donald E Cutlip, Roxana Mehran, Gheorghe Doros, Vladimir Kaplinskiy, Jane Lee, Luke Zheng

Am Heart J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes.
Karina Verma, Andrew Staron, Luke Zheng, Okan Cetin, Gheorghe Doros

Clin Lymphoma Myeloma Leuk· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis.
K H Vincent Lau, Tatiana Prokaeva, Luke Zheng, Gheorghe Doros, Michelle C Kaku

Amyloid· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE.
Andrew J Buckler, Gheorghe Doros, April Kinninger, Suvasini Lakshmanan, Viet T Le, Luke Zheng

Front Cardiovasc Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
Kamil F Faridi, Jordan B Strom, Harun Kundi, Neel M Butala, Jeptha P Curtis, Luke Zheng

J Am Heart Assoc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
Suzanne V Arnold, James A de Lemos, Luke Zheng, Robert S Rosenson, Christie M Ballantyne

Diabetes Obes Metab· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advance Care Planning and End-of-Life Education in Heart Failure: Insights From the NCDR PINNACLE Registry.
Casey E Cavanagh, Lindsey Rosman, Philip Chui, Karl Minges, Nihar R Desai, Luke Zheng

Circ Cardiovasc Qual Outcomes· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans.
Andrew Staron, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.
Aliza Hussain, Salim S Virani, Luke Zheng, Ty J Gluckman, William B Borden

J Am Heart Assoc· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.
Andrew Staron, Luke Zheng, Gheorghe Doros, Lawreen H Connors, Lisa M Mendelson

Blood Cancer J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities.
Andrew Staron, Lawreen H Connors, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala

Blood Cancer J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis.
Shayna Sarosiek, Luke Zheng, J Mark Sloan, Karen Quillen, Dina Brauneis

Blood Cancer J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis